The cannabinoid system and immune modulation (Q35213813)

7 August 2017

1 reference

title

The cannabinoid system and immune modulation (English)

1 reference

7 August 2017

0 references

Thomas W Klein

1 reference

7 August 2017

Cathy Newton

1 reference

7 August 2017

Kellie Larsen

1 reference

7 August 2017

Lily Lu

1 reference

7 August 2017

Izabella Perkins

1 reference

7 August 2017

Liang Nong

1 reference

7 August 2017

Herman Friedman

1 reference

7 August 2017

publication date

1 July 2003

1 reference

Journal of Leukocyte Biology

7 August 2017

published in

1 reference

7 August 2017

1 reference

7 August 2017

1 reference

7 August 2017

page(s)

486-496

1 reference

7 August 2017

cites work

Inflammation and cancer

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0303101

Prostaglandins as modulators of immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0303101

Direct and indirect inhibition of Th1 development by progesterone and glucocorticoids

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0303101

Trends in histamine research: new functions during immune responses and hematopoiesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0303101

Opioid modulation of immune responses: effects on phagocyte and lymphoid cell populations

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0303101

Cannabinoids and the immune system

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0303101

International Union of Pharmacology. XXVII. Classification of cannabinoid receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0303101

Cannabinoids and multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0303101

Drugs and immunity: cannabinoids and their role in decreased resistance to infectious disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0303101

Cannabinoid receptors and immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0303101

The cannabinoid system and cytokine network

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0303101

Cannabinoid receptors and the regulation of immune response

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0303101

Effects of delta-9-tetrahydrocannabinol on human immune function and host defense

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0303101

Isolation, Structure, and Partial Synthesis of an Active Constituent of Hashish

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0303101

Enantiomeric cannabinoids: stereospecificity of psychotropic activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0303101

SR141716A, a potent and selective antagonist of the brain cannabinoid receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0303101

Identification of an endogenous 2-monoglyceride, present in canine gut, that binds to cannabinoid receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0303101

A cannabinoid derived prototypical analgesic

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0303101

Antinociceptive (aminoalkyl)indoles

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0303101

Synthesis and pharmacology of a very potent cannabinoid lacking a phenolic hydroxyl with high affinity for the CB2 receptor.

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0303101

Isolation and structure of a brain constituent that binds to the cannabinoid receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0303101

2-arachidonyl glyceryl ether, an endogenous agonist of the cannabinoid CB1 receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0303101

Isolation and measurement of the endogenous cannabinoid receptor agonist, anandamide, in brain and peripheral tissues of human and rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0303101

Biosynthesis and degradation of anandamide and 2-arachidonoylglycerol and their possible physiological significance

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0303101

Molecular characterization of an enzyme that degrades neuromodulatory fatty-acid amides

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0303101

Vanilloid receptors on sensory nerves mediate the vasodilator action of anandamide

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0303101

Structure of a cannabinoid receptor and functional expression of the cloned cDNA

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0303101

Molecular cloning of a human cannabinoid receptor which is also expressed in testis

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0303101

Schizophrenia and the cannabinoid receptor type 1 (CB1): association study using a single-base polymorphism in coding exon 1

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0303101

Molecular characterization of a peripheral receptor for cannabinoids

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0303101

Molecular cloning, expression and function of the murine CB2 peripheral cannabinoid receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0303101

Cloning and molecular characterization of the rat CB2 cannabinoid receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0303101

G protein-coupled receptors. I. Diversity of receptor-ligand interactions

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0303101

G protein-coupled receptors. III. New roles for receptor kinases and beta-arrestins in receptor signaling and desensitization

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0303101

Regulation of interleukin-12 production by G-protein-coupled receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0303101

Dual intracellular signaling pathways mediated by the human cannabinoid CB1 receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0303101

Role of intracellular loops of cannabinoid CB1receptor in functional interaction with Gα16

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0303101

Morphine and anandamide coupling to nitric oxide stimulates GnRH and CRF release from rat median eminence: neurovascular regulation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0303101

Signaling pathway associated with stimulation of CB2 peripheral cannabinoid receptor. Involvement of both mitogen-activated protein kinase and induction of Krox-24 expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0303101

Induction of interleukin-2 receptor alpha gene by delta9-tetrahydrocannabinol is mediated by nuclear factor kappaB and CB1 cannabinoid receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0303101

Neurobiology Cannabinoids act backwards

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0303101

Neurobiology. How cannabinoids work in the brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0303101

Modulation of transmitter release via presynaptic cannabinoid receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0303101

Retrograde inhibition of presynaptic calcium influx by endogenous cannabinoids at excitatory synapses onto Purkinje cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0303101

Endogenous cannabinoids mediate retrograde signals from depolarized postsynaptic neurons to presynaptic terminals

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0303101

Endogenous cannabinoids mediate retrograde signalling at hippocampal synapses

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0303101

Impairment of antimicrobial activity and nitric oxide production in alveolar macrophages from smokers of marijuana and cocaine

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0303101

Altered cannabinoid receptor mRNA expression in peripheral blood mononuclear cells from marijuana smokers

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0303101

Chronic marijuana smoke alters alveolar macrophage morphology and protein expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0303101

Cannabinoid-receptor expression in human leukocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0303101

Cannabinoid receptors CB1 and CB2: a characterization of expression and adenylate cyclase modulation within the immune system

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0303101

Expression of the CB1 cannabinoid receptor in macrophage-like cells from brain tissue: immunochemical characterization by fusion protein antibodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0303101

Presence and regulation of the endocannabinoid system in human dendritic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0303101

Increased mortality, hypoactivity, and hypoalgesia in cannabinoid CB1 receptor knockout mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0303101

Expression of central and peripheral cannabinoid receptors in human immune tissues and leukocyte subpopulations

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0303101

Differential expression of cannabinoid CB(2) receptor mRNA in mouse immune cell subpopulations and following B cell stimulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0303101

Differential expression of the CB2 cannabinoid receptor by rodent macrophages and macrophage-like cells in relation to cell activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0303101

Effects of long-term exposure to delta9-THC on expression of cannabinoid receptor (CB1) mRNA in different rat brain regions

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0303101

Autocrine and paracrine regulation of lymphocyte CB2 receptor expression by TGF-beta

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0303101

delta 9-Tetrahydrocannabinol, cytokines, and immunity to Legionella pneumophila

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0303101

Inhibition of adenylate cyclase by delta 9-tetrahydrocannabinol in mouse spleen cells: a potential mechanism for cannabinoid-mediated immunosuppression

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0303101

Effects of a cloned cell line with NK activity on bone marrow transplants, tumour development and metastasis in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0303101

Cannabinoid inhibition of adenylate cyclase-mediated signal transduction and interleukin 2 (IL-2) expression in the murine T-cell line, EL4.IL-2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0303101

Interleukin-12 and the regulation of innate resistance and adaptive immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0303101

Increased emotional distress in daughters of breast cancer patients is associated with decreased natural cytotoxic activity, elevated levels of stress hormones and decreased secretion of Th1 cytokines.

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0303101

Morphine directs T cells toward T(H2) differentiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0303101

Norepinephrine: a messenger from the brain to the immune system

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0303101

Delta 9-tetrahydrocannabinol treatment suppresses immunity and early IFN-gamma, IL-12, and IL-12 receptor beta 2 responses to Legionella pneumophila infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0303101

Modulation of cytokine responses in Corynebacterium parvum-primed endotoxemic mice by centrally administered cannabinoid ligands

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0303101

Delta-9-tetrahydrocannabinol inhibits antitumor immunity by a CB2 receptor-mediated, cytokine-dependent pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0303101

Delta 9-Tetrahydrocannabinol regulates Th1/Th2 cytokine balance in activated human T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0303101

Heterologous desensitization of opioid receptors by chemokines inhibits chemotaxis and enhances the perception of pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0303101

Genomic and functional changes induced by the activation of the peripheral cannabinoid receptor CB2 in the promyelocytic cells HL-60. Possible involvement of the CB2 receptor in cell differentiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0303101

Hematopoietic cells expressing the peripheral cannabinoid receptor migrate in response to the endocannabinoid 2-arachidonoylglycerol

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0303101

Anadamide, an endogenous cannabinoid receptor agonist inhibits lymphocyte proliferation and induces apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0303101

Anti-tumoral action of cannabinoids: involvement of sustained ceramide accumulation and extracellular signal-regulated kinase activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0303101

Targeting CB2 cannabinoid receptors as a novel therapy to treat malignant lymphoblastic disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0303101

The endogenous cannabinoid anandamide inhibits human breast cancer cell proliferation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0303101

Involvement of the cAMP/protein kinase A pathway and of mitogen-activated protein kinase in the anti-proliferative effects of anandamide in human breast cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0303101

Suppression of nerve growth factor Trk receptors and prolactin receptors by endocannabinoids leads to inhibition of human breast and prostate cancer cell proliferation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0303101

Antitumor effects of ajulemic acid (CT3), a synthetic non-psychoactive cannabinoid

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0303101

21 January 2018

Identifiers

DOI

10.1189/JLB.0303101

1 reference

7 August 2017

1 reference